EBRO 2017
Definitive chemoradiotherapy in locally advanced esophageal cancer
RTOG 94-05
EBRO 2017
Chemoradiotherapy (standard RT dose) (50.4 Gy + cisplatin/5FU) N= 109
R A N D O M
T1-T4, N0-N1 M0 SCC and AD
Primary endpoint: Survival
Chemoradiotherapy (high RT dose)
(64.8 Gy + cisplatin/5FU) N= 109
higher radiation dose does not improve outcome
Minsky et al. J Clin Oncol 2002
Made with FlippingBook Learn more on our blog